SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " abrams " 42 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
MrBeast Sales Slow, Angel Stock Falls, MUBI and Neon Look for Hits, and Will an NBA Franchise Set a Sales Record?
(Welcome to the Entertainment Strategy Guy, a newsletter on the entertainment industry and business strategy. I write a weekly Streaming Ratings Report and a bi-weekly strategy column, along with occasional deep dives into other topics, like today’s article. Please subscribe.) You probably remember egg prices spiking a few years ago. This led to a lot of debate between the pro-market/pro-competition/antitrust/Neo-Brandesian crowd and the center/center-right/center-left/abundance/libertarian crowd over the cause, whether it was the avian flu outbreak or whether industry consolidation led to price fixing, using avian flu as a convenient cover. Basel Musharbash wrote a whole investigation at BIG looking at it. Well, two years later, we have our answer: it was price fixing. The Justice Department found proof, via emails, of price fixing. Indeed, just the threat of an investigation brought prices down two years ago: I bring this up because at least half a dozen of my favorite political writers and pundits, who were skeptical about price fixing at the time, haven’t written any mea culpas on this issue. It’s really dispiriting and makes it much, much harder to trust their work on other issues. If you take a hard stand on an issue, then you get it wrong, you need to explain how and why you got it wrong. Or update your priors. This is how epistemological bubbles are formed! All of which is to say, it’s time for another installment of “What I Got Right, What I Got Wrong”. Last issue, I mostly focused on the “wrong” side of the equation, so today’s is a bit more balanced, but with one big mea culpa (though I still stand by my original concerns). Let’s dive right in! Subscribe CORRECTION: UFC Didn’t Release Subscriber Data (But Seems to Have Bragged About It Internally) In my analysis of the viewership of UFC Freedom 250, I wrote... “Paramount has also released datecdotes bragging about their subscriber numbers. Earlier this year, they claimed that the first UFC fight on Paramount+ brought in 1 million subscribers.” Well, that datecdote did not come from a PR rep, but from great reporting from James Faris at Business Insider. The actual quote was this: “Paramount’s flagship streaming service generated about a million new subscribers on the day of its first-ever UFC event, Paramount product chief Dane Glasgow told employees in a town hall on Tuesday morning, three staffers who attended the meeting told Business Insider.“ This wasn’t the biggest goof in the world; even Faris emphasized to me that this is more a “clarification” than a correction. Still, it sounds like, internally, the folks at Paramount were very happy about this result—and I’m guessing they were happy with this news getting out—even though the gains didn’t last through the quarter, dropping to 700K adds. RIGHT: MrBeast’s Struggles Continue... I’m very skeptical about MrBeast’s burgeoning media “empire” and, in particular, its $5 billion valuation, as I wrote earlier this year and last year. Sure enough, according to Business Insider, regarding its “booming” consumer products division_:_ “US sales volume grew 13% year-over-year in 2025, following a 33% leap the previous year, according to a presentation deck dated May 2026....A February 2025 investor deck viewed by Business Insider showed Feastables’ net revenue more than doubled in 2024 from 2023, to $215 million, and was forecast to grow 74% in 2025, to $375 million.” [Emphasis mine.] If you told investors that you projected 74% growth but delivered 13%,1 that’s not ideal. But it’s not just MrBeast. Logan Paul and KSI’s Prime had sales drop in half for their energy drinks. It’s one thing to build a successful entertainment company and an entirely different thing to succeed in the heavily-consolidated-but-also-very-competitive consumer packaged goods space! CPGs are dominated by a few firms with very wide moats compared to YouTube, which has few barriers to entry. These businesses require different skill sets and have completely different business environments. WRONG: Does the NBA Have an $8 Billion Bidder? Almost as soon as I published my article about the NBA’s finances, casting skepticism on NBA expansion, I saw this Front Office Sports headline: One group “claims to have already raised $8 billion” for the Vegas expansion team. I mean, wow. That’s just $2 billion less than what the Los Angeles Lakers were valued at when they were sold just last year. And they’re arguably the most popular team in the NBA. (Side note: the new owner is now under an investigation for fraud in how he went about financing the Lakers and the Dodgers purchases.) So much for the “dried up” language I used in that article. (This is why I usually stick to my “Entertainment Nuance Guy” tone in articles...) I went off old information—from April, when I read/heard about the NBA downplaying expansion efforts—instead of doing a quick double-check for new news. That said...if you read the article, the market for Seattle is “slow”, with just one reported bidder. So I wasn’t entirely off. This goof has annoyed me since I first published it, mainly because it undercut that article’s real point, which I stand by: NBA franchises are really overvalued right now. Now, I get why NBA teams are overvalued. When it comes to owning sports teams, it’s basically never wrong to assume that some rich person somewhere will care more about owning a team (or just being part of a group since they’re so expensive) than the actual financials. There are only so many teams to own, and opportunities to buy in preferred markets don’t come along very often. This explains why the teams sell for such high multiples (usually above a 10 to 12.5 revenue multiple, which is very high). You only need one person to overpay! Beyond the ultra-wealthy luxury good explanation, I worry NBA teams are becoming speculative assets. More and more private equity investors are buying into NBA teams. But the value, in owning a team, comes from selling it later, not any meaningful relationship to revenue or profit growth. In other words, the newer NBA owners are increasingly expecting someone later to buy their inflated asset. That’s not sound economics; that’s the “greater fool” theory at work.2 At some point, actually making money has to matter. Especially since revenue growth is now below the growth of the stock market. (And this matters because the NBA doesn’t have easy levers to pull to drastically lower their costs—half of their revenue has to go to players and then you actually have to run a team, including coaching, training, travel, media expenses, and more—or raise revenues aside from one-off expansions in America and overseas.) I just don’t see how investors make their money back buying NBA teams, except for selling at a higher price later on down the line. But if revenue/profit growth continues to slow, at some point, someone will be left holding the bag. RIGHT: Baseball and Basketball are about equally popular. Related to the above, I wanted to cite two quick pieces of evidence for one of my other theories: that the NBA and MLB are about as popular as each other, but the NBA gets much, much better media coverage. One YouGov survey has that fans prefer basketball to baseball by 52% to 48%, which I’m guessing is within the margin of error for that poll. That’s virtually even, meaning they’re about the same popularity. Over on NBC, a recent Red Sox-Yankees game averaged 4 million viewers, higher than Sunday Night Basketball’s average of 3.4 million on the same network. A Yankees-Dodgers game averaged 3.9 million two weeks ago. Not every game averages this much, but it shows you that baseball isn’t far off from basketball, depending on the matchup. Altogether, the NBA is just slightly more popular than baseball, but NBC is paying MLB a fraction of what they pay the NBA, a point I’ve made before. RIGHT: Angel, MUBI and Neon Updates... I’ve long been skeptical about many of Hollywood’s buzziest startups/smaller indie studios. It’s not that they don’t make great movies—films like Anora and Everything Everywhere All at Once are amazing—or that they’re not (rightfully) pushing the majors to make better films, but...they get a ton of hype, and that hype often doesn’t live up to the reality or difficulty in scaling up. Starting with MUBI, well, The Wall Street Journal wrote a feature on MUBI’s struggles last April, best summarized by the subheader “After Sequoia valued Mubi at $1 billion, a left-wing revolt sent the indie film company into a tailspin”. MUBI lost $7.3 million on $200 million in revenue in Q4 2025, but reportedly hit a record 1.7 million subscribers at the end of Q1. As for Neon, Department M purchased a “significant stake” in the company earlier this year. How much is that “stake” worth? According to Deadline, “No financial figures for the Neon-Department M deal were disclosed.” So...that’s not great! If it was a big valuation, we’d hear about. Also, I found this curious: “Both Neon and Department M already have separate partnerships with Qatar. The Qatar Film Committee has a slate deal in place with the former, and a biopic production pact with the latter.” Color me skeptical about much Middle Eastern investment dollars. See: LIV Golf. Finally, as for Angel (formerly Angel Studios), their stock very, very slightly popped last month after Young Washington ($20 million budget) which made $45 million in the US, but their stock is still way down from its opening. Smaller Updates RIGHT: The WGA should focus on antitrust concerns! I’ve been on this for years. Post-WGA/AMTPT deal in 2023, I wrote an article for the Ankler calling on the WGA to focus and organize against industry consolidation. Sure enough, the WGA filed a lawsuit against the Paramount-WBD merger, and people are organizing around this issue now. I wish this energy had coalesced earlier (specifically to lobby Washington much earlier), but better late than never! WRONG: Actually, the chip shortage might be due to market manipulation. In my last “Long Reads for the Long Summer” article, I shared an article about how LLMs are causing memory chip prices to spike, which will make all electronics more expensive. Well, turns out, three RAM manufacturers control 90% of the market, and now a private lawsuit accuses them of price-fixing. So yeah. WRONG/UPDATE: The Odyssey will hold! Two weeks ago, I wrote, “As of this moment, we haven’t had a super-blockbuster, though The Odyssey, Spider-Man: Brand New Day and Avengers: Doomsday could all cross the $500 million mark. (At this point, The Odyssey would need a very strong hold to get there.)” Well, it’s safe to say it’s going to have that hold! It only dropped 30% in weekend two and IMAX screenings are sold out all month. Spider-Man: Brand New Day is also off to a great start. RIGHT: People are rushing to get shows out yearly. I’ve long been bullish on yearly, weekly-released shows, and Leslie Goldberg at The Ankler wrote about how many people in town are now listening. WRONG: Mark Carney reverses Canada’s stance on homegrown production. After writing about Canada installing domestic production quotas, Canada has backed off. WRONG: I don’t trust Spider-Man: Brand New Day’s online “views”. When I originally wrote about the latest Spider-Man film’s record-breaking trailer, I thought this was just YouTube views, but after watching this Corridor Crew video and doing more research, well, it’s all social views of the trailer globally. Really? That stat includes TikTok, Reels and YouTube Shorts views. Basically, I don’t trust it anymore. (This film will probably set record, but I trust the pre-sales data more.) RIGHT: Celebrity Production companies are still struggling. I’ve written about this for years, but the company that I didn’t track was Kevin Hart’s HartBeat, which was valued at $650 million but is struggling now and might just end soon, especially after Kevin Hart pulled his endorsement deals. And Bad Robot is moving to NYC. CORRECTION: SpongeBob is a “second run” title. In my 2025 recap article, I had _SpongeBob SquarePants_labelled as a “library” title, when it is still a “second run” show, with new episodes still coming out on Nickelodeon. CORRECTION: In my last “What I Got Right, What I Got Wrong” update, I offered a correction from Doug Creutz and misspelled TD Cowen. Thanks, Grammarly! 1 Though he could have increased prices to make up for the gap, he couldn’t have increased them that much. 2 There’s a theory, which I think that Daryl Morey created and Bill Simmons popularized, that, to be successful building your team, you only need a handful of bad GMs in the league to take advantage of. To be clear, Daryl Morey’s theory was also for signing bad contracts, that you could always get out of bad contracts. Basically, there’s always someone who will make a bad trade. It’s not the same exact thing, but similar enough to the Greater Fool Theory that I really like it.
The science behind why music gives you goosebumps
Have you ever got the chills listening to Tchaikovsky, a shiver from Shakira or goosebumps from Gracie Abrams?
Daniel Radcliffe and Mariska Hargitay Toast ‘Every Brilliant Thing’ and the Center for Youth Mental Health
Dr. Zandy Forbes, Ayesha Shand, Dr. Charlie Shaffer, Elizabeth Shaffer, and Anna Wintour served as co-hosts for the evening, which welcomed Louisa Jacobson, Derek Blasberg, Natalie and Ava Massenet, and more.
Gracie Abrams understands nepotism discourse about her, admits Hollywood parents provided 'a safety net': 'I get it'
Gracie Abrams understands why she's frequently brought up in conversations about nepotism, and said that her parents' success in Hollywood provided 'a safety net': 'I get it.'
Yankees Urged To Go Big With CJ Abrams Blockbuster Deal
The New York Yankees shouldn't be afraid to make a splash this summer.
Stacey Abrams on the FBI’s Fulton County Raid—and the Future of US Elections
Kathleen Sebelius joins The Stakes to explain how political interference, staffing cuts, and weakened agencies are undermining public health.
‘Resident Evil’ scares up franchise-best $60 million premiere, pushing horror to new box office record
This year’s slate of horror films have put 2026 in contention for the highest grossing box office year in the genre’s history following the $60 million franchise-best open for Zach Cregger’s ‘Resident Evil.’
A Philadelphia-area developer plans to buy, redevelop Concord Mall
Abrams Realty and Development is reportedly under contract to purchase Concord Mall from its current owners, Namdar Realty Group.
Can You Get Actually Swallowed By A Whale? Here's The Real Science Behind 'Whalefall'
'Whalefall' is a whale of a tale, but poor Austin Abrams might be a little luckier in reality.
Campus Politics in City Hall: The Civic Culture We Tolerated in Universities Is Now Shaping How Cities Are Governed.
New York does not need less debate. It needs a restoration of civic norms. The question is no longer what we tolerate on campus. It is what we are willing to accept from the people who govern us.
FDA wants feedback on how to regulate generative AI in medicine
“Generative AI-enabled medical devices are poised to reshape the health technology landscape, and the FDA has an important responsibility to provide thoughtful leadership for this new era,” says radiologist Rick Abramson, MD.
Nationals get conflicting CJ Abrams trade deadline prediction
This is an odd pair of predictions for the Nationals.
Craig Leipold, Local Businesses Buy Saint Paul Hotel
The Minnesota Wild owner, Ecolab, and Securian Financial are new owners of the landmark hotel, which will get a major renovation.
"It's a disaster": Multiple businesses at total loss after Arlington structure fire
Several Arlington business owners are grappling with a total loss after a 4-alarm fire raged through a building on W. Abrams Street on Monday afternoon.
Music Review: Gracie Abrams confronts crises on 'Daughter From Hell'
Crises loom across singer-songwriter Gracie Abrams’ third album, “Daughter from Hell.” The resulting 16 tracks are darker than her previous two records, writes The Associated Press' Elise Ryan in her
‘Whalefall’ ending explained: Who survives? What happened on the boat? How does it differ from the book?
Austin Abrams and Josh Brolin star in Whalefall, a heart-racing thriller based on Daniel Kraus’ novel. Who survives? What happened on the boat? How does it differ from the book? Here’s the answers.
'Whalefall' Writer Explains the Real Science That Drives the Survival Thriller
What happens in 'Whalefall' is surprisingly accurate to the real ordeal, tapping deep into primal human fears.
Rusty Taco expands nontraditional footprint through airport, entertainment venues
Rusty Taco is expanding its national footprint through nontraditional venues, including airports, convenience stores and entertainment destinations. The Dallas-based street taco brand will open its second location at Washington Dulles International Airport and its first at Norfolk International Airport this fall. It also plans to open a location at Bowlski's, a bowling alley and live music venue at 1825 Abrams Parkway in Dallas.
'The End of Oak Street: Could JJ Abrams' new 'Twilight Zone meets Jurassic Park' movie be the sleeper hit of the summer?
"I think our house, our neighborhood, our whole street, has moved."
Dodgers Should Jump on Proposed Trade for Abrams, Wood
After a disappointing postseason exit, the Los Angeles Dodgers could secure a dynasty by trading for the Washington Nationals' young stars.
Too-early MLB trade deadline preview: 10 candidates to move, including C.J. Abrams and Tarik Skubal
With Opening Day just around the bend, teams are already eyeing how they can improve
Tocqueville’s Political Science of American Democracy
The dispersal of power that makes the republic safe for its citizens is the same dispersal that leaves those outside it with nowhere to appeal.
New Editorial Leadership for Twin Cities Business
MSP Communications announces appointment of Platt and Rybak to new roles.
The Odyssey to Gracie Abrams: your complete entertainment guide to the week ahead
Matt Damon dons the sword and sandals in Christopher Nolan’s epic, while the LA singer-songwriter shares more arena-friendly scream-along anthems
Anthropic debuts Claude Science, an AI product for bioscience
On Tuesday, Anthropic announced Claude Science, a new product that company leaders describe as an AI workbench for scientific research.
An Evening of Hope: The Center for Youth Mental Health Hosts its Annual Benefit Dinner
The annual benefit dinner for the Center for Youth Mental Health at NewYork-Presbyterian was hosted by Anna Wintour, Mariska Hargitay, Dr. Zandy Forbes, Dr. Brian G. Donley, and Kim Richter Shirley and Jon Shirley.
AFT raises mold, health concerns at Abrams Elementary in Bessemer
ABC 33/40 in Birmingham, Alabama offers news, sports, and weather reporting for the surrounding communities including Tuscaloosa, Anniston, Cullman, Gadsden, Talladega, Sylacauga, Carbon Hill, Jasper, Hoover, Bessemer, Vestavia Hills, Alabaster, Trussville and Homewood.
Eversource, Blumenthal, data centers: CT politics news
Plus: Stacey Abrams in CT, a federal investigation into sexual assault handling, and education accountability metrics.
MLB rumors: Major trade candidate could miss rest of 2026 with injury; Nationals taking calls on CJ Abrams
The trade deadline is barely a week away
Is 50 the new 60?
Subscribe TL;DR: Younger generations are showing signs of worse health compared to earlier-born cohorts at the same age This backward “drift” is showing up both in mortality risk and chronic disease Worsening trends in obesity and diabetes are the most consistent signals Taking the long view, we’ve made astonishing gains in health and life expectancy in the last century. Global average life expectancy has more than doubled from 32 years in 1900 to 73 years in 2024. (But don’t forget, there were still old people when life expectancy was 32). As people lived longer, they also generally lived healthier along the way. It turns out that avoiding things that can kill you early, like malnutrition and lots of childhood infections, also keeps you healthier later in life. In a classic 2004 paper, Finch and Crimmins proposed that cohorts of children who benefited from fewer early life infections had less lifetime exposure to inflammation and cardiovascular disease later in life, accelerating mortality improvements at older ages. Poor nutrition in the womb has also been linked to a higher risk of later chronic disease. The upshot is that improvements in childhood health can pay dividends many decades later. The combination of better living conditions (nutrition, sanitation) and medical advances (antibiotics, vaccines, blood pressure meds, etc) meant that people’s healthy lifespan generally expanded, even as they lived longer. Aging researchers call this best-case scenario “compression of morbidity”—meaning we delay the onset of disease and disability even faster than the years of life we are adding. During my 20+ year research career, we could generally bank on the idea that younger generations would not only live longer but also keep getting healthier along the way. “60 is the new 50” as they say… Enter “Generational Health Drift” Sadly, this expectation of steady progress may be changing. You’ve probably heard that US life expectancy gains have slowed to a crawl in the past couple of decades. Mortality improvements are also slowing (though less dramatically) in many other high-income countries (you can read more about that in a review paper I wrote here). Mortality is a very blunt health measure, but it is often a good barometer for the broader population health trends happening underneath. And we are now seeing that younger generations may be in worse health at similar ages compared to earlier born cohorts. My collaborator Prof. George Ploubidis at University College London coined this worsening health in more recently born cohorts “generational health drift.” “Generational health drift” is bad news on multiple fronts. Most obviously, we don’t want our health progress to go backward. But the timing is also bad, since our populations are aging. In demographic terms, “population aging” means that the proportion of the population at older ages (i.e >65 years) is increasing. Fun demography fact: Current population aging is not due to the recent declines in the birth rates making the news, but declines in fertility decades ago, after the “baby boom.” As baby boomers reach older ages, the smaller cohorts behind them mean the percentage of older adults will increase. For example, the share of the population age 65 and older in the US increased from 12.4% in 2004 to 18.0% in 2024. This story of population aging was written long ago. Many worry that population aging will put pressure on health care and pension systems. But if people reach older ages in better health than in years past, those fiscal pressures would be less dire than projected. Healthy older people can also continue to contribute to society in many valuable ways, including paid work, caregiving, community service….even high political office 🤷. On the flip side, if younger generations reach retirement age in worse health and with more disabling conditions, this could magnify the societal challenge of population aging. Evidence for worsening generational health A recent paper that I LOVED in the Proceedings of the National Academy of Sciences by Dr. Leah Abrams and colleagues examined which birth cohorts (aka generations) were behind worsening US mortality. Behold the Lexis diagram (cue swooning demographers). Calendar time is on the x-axis, age on the y-axis. Birth cohorts can be followed over time as they age on the diagonal lines moving up and to the right. This figure plots the year-on-year % change in all-cause mortality at a given age. Green shading indicates mortality improvements over time, white is stagnation, and gray shading indicates worsening mortality. Following the diagonal line for those born in 1950, you can see a noticeable shift from green to gray that follows this cohort for most of their lives. This gray shading shows generally worsening mortality for the 1950 to 1959 birth cohorts compared to their predecessors across all ages. Concerningly for my GenX and elder millennial peeps, there was also a deterioration in mortality for birth cohorts born in the 1970s and 1980s, visible as dark gray areas at ages 30 to 45 during the 2010s. While some of these mortality changes reflect specific shocks such as the opioid epidemic, most deaths still occur from major causes of death such as cardiovascular disease and cancer. For cancer, the gray in the top left corner of the figure below reflects the legacies of smoking for older cohorts, followed by a period of green with improvements in cancer mortality as smoking rates declined. But the white/gray shading in the bottom right corner highlights a stagnation and reversal of the cancer trends, with cohorts born around 1970 to 1985 experiencing worsening cancer mortality. This deterioration was most noticeable for colon cancer mortality, possibly linked to obesity or dietary factors. Not just dying more, but less healthy along the way. A recent paper by Dr. Laura Gimeno of University College London (of which I am a co-author), found evidence that more recently born cohorts in Great Britain have stagnating or worsening health. A stylized picture of what“generational health drift” might look like: The review paper found: Rates of childhood overweight and obesity were highest among Gen Z. Rates of diabetes in the 40s almost doubled from 3.1% among the Baby Boomers to 5.9% in Generation X. Gen Z reported higher rates of poor mental health in adolescence compared to earlier-born groups. These UK results are consistent with studies showing worsening health across generations in the US as well. A 2021 US study found that more recently born cohorts had worse biological markers (like blood pressure and blood sugar) than earlier generations at the same age. A separate 2022 study of Americans aged 50 and over found that more recently born generations had a higher number of chronic diseases, with younger age of disease onset. A 2024 Lancet paper found that in the US, women born in 1945 had 33% obesity prevalence at age 50, rising to 48.2% for women born in 1970 turning 50. So what’s going on, and can we turn it around? We don’t have a definitive answer for what’s causing the deteriorating health of younger cohorts, but circumstantial evidence points to worsening trends in obesity and diabetes in both the US and UK. Remember that cohort trends reflect lagged effects of early environments, and younger generations have faced both earlier onset and more severe obesity across their lifetimes. Despite these very concerning trends, the future is not set in stone. We’ve reversed poor generational health trends before: drops in smoking are a major reason cancer and heart disease deaths fell so dramatically in recent decades. GLP-1 drugs may finally turn the tide against rising rates of obesity and diabetes, though it is still early days. But things could also get worse…for example from a return to higher levels of childhood infectious diseases that can have a lasting impact on health. See for example: [ ](https://jenndowd.substack.com/p/dont-you-forget-about-measles-the) [ Don’t You Forget About Me(asles): The Virus That Erases Immune Memory ](https://jenndowd.substack.com/p/dont-you-forget-about-measles-the) Jenn Dowd, PhD · March 24, 2025 [ Read full story ](https://jenndowd.substack.com/p/dont-you-forget-about-measles-the) Even as an optimist, emerging data on the “generational health drift” has my full attention. For most of my research career, we took it for granted that each generation would be healthier than the last. But if present trends continue, **50 could be the new 60….**and Gen Z celebrities will soon look older than Paul Rudd :). Stay well, Jenn Share the Health! If you found this post useful, please share it with a friend. Share
Music Review: Gracie Abrams confronts crises on 'Daughter From Hell'
Crises loom across singer-songwriter Gracie Abrams’ third album, “Daughter from Hell.”
How Jesse Jackson used the South to reshape Democratic politics
"He was a child of the South, and he understood the extraordinary power wielded by the state," Stacey Abrams said.
5 players creating early MLB trade buzz: Luis Arraez, CJ Abrams, Willson Contreras and more
Sony Interactive Entertainment to produce and publish Bad Robot Games-developed co-op shooter for PS5, PC
Sony Interactive Entertainment has announced a partnership with Bad Robot Games, a division of the film, television, and theater production company Bad Robot founded by JJ Abrams, to produce and pu…
Trump’s Former Venezuela Envoy Torches His Takeover Plans
“It’s too complex for us to run,” said Elliott Abrams, theorizing that Trump’s decision to announce the U.S.’s takeover of Venezuela was wholly spontaneous.
Leonard Abramson, Health Care Innovator and Philanthropist, Dies at 93
He created U.S. Healthcare, one of the first H.M.O.s, and used his great wealth from the sale of the company for causes like advancing cancer research.
Howard Fensterman
Howard Fensterman is the managing partner and co-founder of Abrams Fensterman, a full-service law firm representing healthcare professionals, physicians, licensed professionals, businesses and institutions in regulatory, corporate, litigation and transactional legal matters.
Two Washington Nationals Set Milestones in Win vs. St. Louis
Both Cade Cavalli and CJ Abrams set new franchise records for the Washington Nationals in a 9-1 win vs. St. Louis Cardinals
Abramson advancing research at intersection of health, inequality and AI
Corey Abramson's research earns him a year in residence at the Center for Advanced Study in the Behavioral Sciences (CASBS) at Stanford University.
Radiologist FDA leader believes generative AI should be evaluated like human docs
Rick Abramson, MD, director of the FDA’s Digital Health Center of Excellence, recently spoke during a panel held in Boston by industry lobbying group AdvaMed.
The Stacey Abrams era in Georgia is over, for now
The move clears the way for new Democrats, for better and worse.
FDA digital health leader promises generative AI regulatory guidance is coming
FDA expects to issue guidance on policies regarding generative AI devices, according to Rick Abramson, the agency’s head of digital health policy.